Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Rank	Δ	Cancer	Trial Gap Index (percentile points)	Percentile	Confidence	Sources	Why #n?
1	=	Malignant Colon Neoplasm	+55.6	100	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 24801 formula percentile(mortality_count) − percentile(active_trials) activity 225 burdenPercentile 92.6 activityPercentile 37 ranking row 2592973
2	=	Malignant Vulvar Neoplasm	+18.5	96.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 765 formula percentile(mortality_count) − percentile(active_trials) activity 54 burdenPercentile 25.9 activityPercentile 7.4 ranking row 2592974
3	=	Cutaneous Melanoma	+14.8	92.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 2779 formula percentile(mortality_count) − percentile(active_trials) activity 78 burdenPercentile 37 activityPercentile 22.2 ranking row 2592975
3	=	Malignant Laryngeal Neoplasm	+14.8	92.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 779 formula percentile(mortality_count) − percentile(active_trials) activity 66 burdenPercentile 29.6 activityPercentile 14.8 ranking row 2592976
3	=	Malignant Vaginal Neoplasm	+14.8	92.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 382 formula percentile(mortality_count) − percentile(active_trials) activity 31 burdenPercentile 14.8 activityPercentile 0 ranking row 2592977
6	=	Malignant Ovarian Neoplasm	+14.8	81.5	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 14414 formula percentile(mortality_count) − percentile(active_trials) activity 684 burdenPercentile 85.2 activityPercentile 70.4 ranking row 2592978
7	=	Malignant Bladder Neoplasm	+7.5	77.8	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 3882 formula percentile(mortality_count) − percentile(active_trials) activity 346 burdenPercentile 51.9 activityPercentile 44.4 ranking row 2592979
8	=	Malignant Pancreatic Neoplasm	+7.4	74.1	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 15336 formula percentile(mortality_count) − percentile(active_trials) activity 904 burdenPercentile 88.9 activityPercentile 81.5 ranking row 2592980
9	=	Malignant Kidney Neoplasm	+3.7	70.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4554 formula percentile(mortality_count) − percentile(active_trials) activity 453 burdenPercentile 59.3 activityPercentile 55.6 ranking row 2592981
9	=	Malignant Thyroid Gland Neoplasm	+3.7	70.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 786 formula percentile(mortality_count) − percentile(active_trials) activity 176 burdenPercentile 33.3 activityPercentile 29.6 ranking row 2592982
11	=	Malignant Breast Neoplasm	0	63	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 41394 formula percentile(mortality_count) − percentile(active_trials) activity 2627 burdenPercentile 96.3 activityPercentile 96.3 ranking row 2592983
11	=	Malignant Gastric Neoplasm	0	63	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 5128 formula percentile(mortality_count) − percentile(active_trials) activity 652 burdenPercentile 66.7 activityPercentile 66.7 ranking row 2592984
11	=	Malignant Lung Neoplasm	0	63	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 65606 formula percentile(mortality_count) − percentile(active_trials) activity 2644 burdenPercentile 100 activityPercentile 100 ranking row 2592985
11	=	Malignant Rectal Neoplasm	0	63	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 3778 formula percentile(mortality_count) − percentile(active_trials) activity 386 burdenPercentile 48.1 activityPercentile 48.1 ranking row 2592986
15	=	Multiple Myeloma	-3.7	48.1	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 5234 formula percentile(mortality_count) − percentile(active_trials) activity 814 burdenPercentile 70.4 activityPercentile 74.1 ranking row 2592987
16	=	Malignant Cervical Neoplasm	-3.7	44.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4092 formula percentile(mortality_count) − percentile(active_trials) activity 505 burdenPercentile 55.6 activityPercentile 59.3 ranking row 2592988
17	=	Malignant Salivary Gland Neoplasm	-3.7	40.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 266 formula percentile(mortality_count) − percentile(active_trials) activity 63 burdenPercentile 7.4 activityPercentile 11.1 ranking row 2592989
18	=	Malignant Hypopharyngeal Neoplasm	-3.7	37	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 91 formula percentile(mortality_count) − percentile(active_trials) activity 53 burdenPercentile 0 activityPercentile 3.7 ranking row 2592990
19	=	Malignant Central Nervous System Neoplasm	-3.7	33.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 5594 formula percentile(mortality_count) − percentile(active_trials) activity 823 burdenPercentile 74.1 activityPercentile 77.8 ranking row 2592991
20	=	Malignant Mesothelioma	-7.4	29.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 464 formula percentile(mortality_count) − percentile(active_trials) activity 96 burdenPercentile 18.5 activityPercentile 25.9 ranking row 2592992
21	=	Malignant Anal Neoplasm	-7.4	25.9	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 326 formula percentile(mortality_count) − percentile(active_trials) activity 68 burdenPercentile 11.1 activityPercentile 18.5 ranking row 2592993
22	=	Malignant Uterine Corpus Neoplasm	-7.5	22.2	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 3185 formula percentile(mortality_count) − percentile(active_trials) activity 411 burdenPercentile 44.4 activityPercentile 51.9 ranking row 2592994
23	=	Non-Hodgkin Lymphoma	-11.1	18.5	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 10595 formula percentile(mortality_count) − percentile(active_trials) activity 2168 burdenPercentile 81.5 activityPercentile 92.6 ranking row 2592995
24	=	Hodgkin Lymphoma	-11.1	14.8	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 598 formula percentile(mortality_count) − percentile(active_trials) activity 179 burdenPercentile 22.2 activityPercentile 33.3 ranking row 2592996
25	=	Leukemia	-11.1	11.1	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 9638 formula percentile(mortality_count) − percentile(active_trials) activity 1769 burdenPercentile 77.8 activityPercentile 88.9 ranking row 2592997
26	=	Malignant Liver Neoplasm	-22.2	7.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4868 formula percentile(mortality_count) − percentile(active_trials) activity 906 burdenPercentile 63 activityPercentile 85.2 ranking row 2592998
27	=	Malignant Esophageal Neoplasm	-22.3	3.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 2923 formula percentile(mortality_count) − percentile(active_trials) activity 518 burdenPercentile 40.7 activityPercentile 63 ranking row 2592999
28	=	Malignant Nasopharyngeal Neoplasm	-37	0	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 206 formula percentile(mortality_count) − percentile(active_trials) activity 261 burdenPercentile 3.7 activityPercentile 40.7 ranking row 2593000

Data updated 16 hours agoSource updated unknown28 eligible entities · inputs hash c3302d42e4090297a77aafcf

Methodology

How this table was built

Formula: percentile(mortality_count) − percentile(active_trials)
Version: ci-trial-gap-v1
Scope: USA · Female · all ages · 2001 · top-level cancers
Scope key: geo=USA|sex=female|age=all|year=2001|level=top
Eligible entities: 28
Generated: Sep 29, 2026, 06:30 AM UTC
Inputs hash: c3302d42e4090297a77aafcf
Sources: U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality clinicaltrials cdc-wonder seer iarc-globocan
Aggregation: none

Eligibility

requires: mortality_count
active_trials
entityLevel: top

Full methodology · ties share a rank (1, 2, 2, 4) · previous rank refers to the last snapshot of the same scope.

Download CSV (with attribution)

Burden and lethality metrics depend on registry definitions (site groups, standard population, estimate type). Compare only within one table.